Casual blood glucose test misses majority of gestational diabetes cases

When screening pregnant women for gestational diabetes, casual blood glucose testing misses 70% of the cases.

Illumina faces SEC probe over Grail acquisition

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Securities and Exchange Commission

August 14, 2023

$400 million for an obesity drug startup? A new venture is a sign of the times

Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup led by a chief

October 1, 2024

Illumina names former Agilent exec as CEO, months after parting ways with deSouza

Illumina has picked Jacob Thaysen as its new CEO, roughly three months after the company parted ways with Francis deSouza following a fight with an activist

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.